Alzheimer’s disease is a slowly progressive disorder characterized by a long preclinical phase with gradually increasing levels of Alzheimer’s disease -related pathological processes, including amyloid, tau and brain atrophy40, and cognitive decline, starting up to a decade prior to disease onset40,41. This evidence concerns the gene MAPT and Alzheimer disease.